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Jackson Automatic monitor for lead emissions from stacks
them and then using these results to set the corresponding
monitor readings at the correct level. Once locked-in in this
way changes would only be needed if the stack conditions
were altered or some significant change made in the sampling
procedure.
Conclusion
The design and evaluation of an automated instrument for
the continuous monitoring of lead emissions from stacks is
described. This is one of a number of such monitors being
designed and evaluated for the Alkali Inspectorate in their
search for a reliable, economical instrument for the contin-
uous monitoring of emissions of metal dust and fume from
stacks and ducts. The basic concept of the described instru-
ment is seen to be valid but certain problems have been
discovered during the evaluation stage. Until the modifications
discussed above have been made, and the monitor retested
on-site, it is not possible to say that a proven instrument,
based on the concepts described, is currently available.
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Introduction
The Kodak Ektachem analytical system is a unique concept
recently introduced into the field of clinical chemistry, which
applies the company’s considerable experience in photo-
graphy. In contrast to conventional clinical analysis, the
chemistry is carried out on a thin film of interacting chemical
layers termed a slide. In the analytical instrument produced
by Kodak, a dispenser places a drop of serum onto the slide
which is then moved into an incubator to develop the colour
reaction. The measurements are carried out by reflectance
densitometry.
Thin film chemistry
The principles of this technique can be described by reference
to the analysis of urea. Figure shows a schematic diagram
of the slide used and also illustrates the chemistry integrated
into the multilayers. The spreading layer is an isotropically
porous non-fibrous layer with an 80% void volume and a
mean pore size of 1.5 microns. The spreading and metering
action which is aided by surfactants, compensates for any
differences in sample size (nominally 10/.tl are applied) and
serum viscosity. A constant volume per unit area is then
naturally applied to subsequent layers of the slide. High
molecular weight materials, such as protein, are removed
by this layer and consequently do not interfere with the
subsequent analysis. Titanium dioxide is incorporated in
the spreading layer to improve its reflectivity.
It also acts as a white background for reflectance measure-
ments against which the colour density produced in the
indicator layer can be measured. The reagent layer contains
the urease which catalyzes the hydrolysis of urea in the
sample to produce ammonia. Water from the serum sample
applied, swells the gel allowing the urea to diffuse into the
layer. The layer is buffered to pH 7.8 and this maintains the
* Translated from the German by R. Arndt and P.B. Stockwell.
The German text of this paper will.be published in part in the
November 1979 issue of G-I-T Labormedizin.
ammonia at a low level, and subsequently extends the
range of the assay. A third layer consisting of cellulose
acetate butyrate with selective permeability, allows non-
ionic materials such as ammonia and water to pass through to
the indicator layer. Ionic compounds are excluded, providing
some degree of selectivity. The indicator layer consists of a
gel-binder incorporating the indicator reagent, in this
example, N propyl 4 2, 6 dinitro- 4 chlorobenzyl
-quinolinium ethane sulphonate. Free ammonia which
diffuses into this layer reacts with the indicator to form a
dye which has a molar absorptivity of approximately 5000
and a broad absorption peak at 520 nm. The reflectance
density is measured off the peak at 670 nm. The final layer
is a clear polyester support upon which all the other layers
are coated. It is transparent and allows measurement of the
dye density formed in the indicator layer. Slides for urea
and glucose determination are also available. Research has
been strongly stimulated by the knowledge that Kodak
had developed the multilayer film technique and many
more methods are forthcoming.
The authors’ experiences with the technique for the
determination of the concentration of glucose and urea in
serum are presented in this paper. The experimental work
was carried out using an investigational unit over a four
month period. The evaluation was directed towards assessing
the analytical reliability of the thin film concept rather than
to the technical reliability and practicality of the instrument
used.
In the technique described in detail elsewhere [1, 2],
drops of serum are directly applied to the analytical slides.
Relatively high concentrations of the analytes to be
determined, and also any interferences in the undiluted
sample, are therefore in contact with the reagents held in the
individual layers. In conventional techniques, samples are
usually diluted by factors of 1:10 or 1:1000. Special
attention in this evaluation was focussed on determining any
possible interferences due to various exogenic and endogenic
compounds present in the serum samples.
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Since reactions in this technique take place in the thin
films physical parameters such as difusion, capillary adhesion
and viscosity attain a new importance in clinical chemistry.
Unlike absorbance, end measurement by reflectance is not a
linear function of concentration.
Methodology
Glucose slide
The method for determination of glucose concentration is
similar to the method described by Trinder [3]. H202 is
formed in the presence of glucoseoxidase (EC 1.1.3.4.) and is
determined by a subsequent indicator reaction with peroxid-
ase (EC 1.11.1.7.). However, phenol is replaced by 1,7-
dihydroxynapthalene (DHN). Details on the various layers
in the film are shown in Table 1.
The wavelength maximum of colour absorption appears at
a wave length of 495 nm, but in order to improve the linearity
of the measurement to reduce interference by bilirubin,
slides are measured at 540 nm in this system. The slide
reaction takes place rapidly, however there is also a slow
mutarotation of a to/-glucose. After 7 minutes 80% of the
total glucose is converted to product.
Urea slide
The method for determination of urea concentration, has
already been described above. The five layers of the film are
summarized in Table 2. In the urea also
the reaction does not proceed to completion.
The Ektachem system was operated according to the
instructions given by the manufacturer. The following
comparative methods were used. A kinetic assay of urea using
the urease-GLDH-principle on a Gemsaec analyser [4], a
glucose assay using the hexokinase method after Somogyi
deproteinization on an endpoint automatic analyzer 5030
from Eppendorf Geritebau GmbH [5]. In addition,
reference was made to an assay using the hexokinases
method on a SMA 12/60 of Technicon GmbH (D-6368 Bad
Vilbel).
Table Glucose method
spreading layer
reagent layer
substrate
stability
cellulose-acetate pigmented with Ti02
thickness 100/m
average diameter of pores 1,5/m
gelatine
thickness 10mm
pH 4,8
GOD (Aspergillus niger)
POD (horse-radish)
4- aminophenazon (4-aminoantipyrin)
1,7-DHN
polyethylene-terephtalate
at least year at +4C
Table 2 The 5 thin film layers of the urea slide
i’" spreading layer Ti02-cellulose-acetate
2 reagent layer urease
gelatine
pH 7.8
3 semipermeable layer cellulose-acetate-butyrate (0.5/m)
4 indicator layer Merocyaninl) in cellulose-acetate
5 substrate polyethylene-terephtalate
1) N-propyl-4-(2, 6-dinitro-4-chlorobenzyl) quinolinethane-sulfonate
(pH-indicator)
Interferences
Interferences have been tested in a similar manner to that
reported earlier [6]. A reference pool of serum was divided
into several samples to which various pharmaceuticals (pure
compounds) were added. A control sample (i.e. no
compounds added) was also prepared from the batch. Phar-
maceuticals were applied in concentrations ten times lower
than those used in earlier studies [6, 7] in order to correspond
more closely to actual therapeutic conditions. From the
results obtained using the control samples, the range of
tolerance was determined (mean value +3 standard deviat-
ions). Any interference due to proteins in human serum was
tested using samples with pathological composition of
Spreading Layer
Reagent Layer
Semipermeable membrane
I"-
Indicator Layer
Support Layer
Figure 1. Schematic diagram of the slide used, illustrating
the chemistry integrated into the multilayers.
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proteins, and with solutions of albumin (Rinder-Albumin
reinst, Behringswerke AG, D-3 550 Marburg).
Interferences due to endogenic chromogenes (bilirubin,
haemoglobin, turbidity) were investigated using comparative
measurements, outlined above [4, 5]. The corresponding
analytes were added to human sera in pathological concentr-
ations.
Statistics
The precision was determined using the scheme described
in the NCCLS report [8]. Three control sera with different
concentrations (Tables 3 and 4) were determined using a
fixed permutational scheme [8]. They were determined in
two daily series throughout a 20 day period, and results
were performed in duplicate.
3l
10-
Figure 2. Linear range for determination of glucose with
aqueous ((C)-(C)) and albuminic solutions ofglucose (o-o).
The calibration was carried out with 3 glucose solutions
(3, 15, 30 mmol/l) with resp. without albumin.
30-
lO-
Figure 3. Linear range for determination of urea with
aqueous ((C)--(C))and albuminic solutions of urea ( ).
The calibration was carried out with 3 urea solutions (5,
20, 40 mmol/l) with resp. without albumin,
Table 3 Day-to-day precision of determination of glucose
concentrations with the Ektachem system using the NCCLS
recommendations.
run
serum l=morning ’-:Psmn mean S coeff n
2=afternoon in run value var
High control’ 28,38 0,45 1,60 20
2 Geo A 2 26,08 0,49 1,88 19
3 Geo A 3 26,07 0,49 1,88 21
4 High control’ 2 28,52 0,44 1,53 20
5 Geo A 2 26,23 0,58 2,20 22
6GeoA 3 26,19 0,50 1,92 22
7 Low control’ 3,38 0,11 3,25 21
8PathonormL 2 1,43 0,10 6,99 21
9 Pathonorm L 3 1,42 0,11 7,75 21
10 Low control’ 2 3,37 0,10 2,97 21
11 Pathonorm L 2 1,42 0,11 7,75 21
12 Pathonorm L 3 1,42 0,10 7,04 21
13 Wellcomtrolll’ 11,65 0,20 1,72 20
14 Wellcomtrol 1" 2 6,29 0,13 2,07 20
15 Wellcomtroll 3 6,29 0,13 2,07 20
16 Wellcomtro111’ 2 11,63 0,23 1,98 20
17 Wellcomtrol 1" 2 6,29 0,12 1,91 20
18Wellcomtroll 3 6,30 0,09 1,43 19
19 Pathonorm L" 1,42 0,10 7,04 20
20 Pathonorm L" 2 1,41 0,11 7,80 21
21 ttigh control"’ 28,33 0,47 1,66 11
22 High control’" 2 28,46 0,50 1,76 14
including a possible cross contamination (concentration of
preceding sample differed)
including a possible cross contamination due to change from high
to low concentration
"’including a possible cross contamination due to change from low
to high concentration
Table 4 Day-to-day precision of determination of urea
concentrations with the Ektachem system using the NCCLS
recommendations
run
serum morning position mean S coeff n
2=afternoon in run value vat
High control* 37,52 0,70 1,86 20
2 Geo A 2 31,98 0,46 1,43 19
3 Geo A 3 31,75 0,47 1,49 21
4 High control* 2 37,74 0,74 1,96 21
5 GeoA 2 31,91 0,66 2,06 22
6GeoA 3 31,99 0,50 1,56 22
7 Low control* 3,26 0,11 3,43 20
8 Pathonorm L 2 2,94 0,12 3,91 22
9 Pathonorm L 3 2,92 0,10 3,51 22
10 Low control* 2 1 3,27 0,11 3,44 21
11 Pathonorm L 2 2,93 0,11 3,78 22
12 Pathonorm L 3 2,93 0,11 3,72 22
13 Wellcomtrol II* 29,44 0,4’9 1,67 21
14 Wellcomtrol I** 2 9,12 0,23 2,50 22
15 Wellcomtrol 3 9;07 0,24 2,64 22
16 Wellcomtrol II* 2 29,44 0,46 1,55 21
17 WellcomtrolI** 2 9,09 0,25 2,71 22
18 Wellcomtrol 3 9,12 0,22 2,45 21
19 Pathonorm L** 2,94 0,10 3,28 20
20 Pathonorm L** 2 2,93 0,09 3,22 22
21 High control*** 37,47 0,61 1,62 12
22 High control*** 2 37,70 0,40 1,07 13
* including a possible cross contamination (concentration of
preceding sample differed)
** including a possible cross contamination due to change from
high to low concentration
** including a possible cross contamination due to change from low
to high concentration
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Within-run imprecision was calculated from the second and
third value (position in run, see Table 1), and between-day
imprecision from the second, respectively the third value of
a triple determination.
Correlation coefficients were calculated using standard-
ized principle component analysis [9, 10]. The samples of
serum were selected from those specimens received daily in
the authors’ central laboratory, approximately 25% of the
results were below, 50% within, and 25% above the normal
range.
Results
Precision
The between-day imprecision with 10 different control sera
varied from 0.9% to 2.7% for glucose concentration, and
from 1.9% to 3.1% for urea concentration (Table 5).
The concentration of the preceding sample does not have
an influence on the precision since as expected, the system
works without cross contamination (Tables 3 and 4).
The within-run imprecision is smaller by approximately
a factor of 0.3 to 0.7 than the between-day imprecision
(Table 6).
Accuracy
The range of linearity for glucose (1.1 to 33.3 mmol/1) and
for urea (0.7 to 42.7 mmol/1) as specified by the manu-
facturer, was confirmed using aqueous and albumin standard
solutions (Figures 2 and 3).
Comparing the various methods used, a very good
correlation was obtained with patient sera over the entire
range of measurements (Figures 4 and 7). The mean values
between Ektachem and the comparative method (2and 9 in
Figure 4. Comparative determination ofglucose in sera of
patients using the Ektachem system and the Eppendorf
endpoint analyzer 5030. Analysis of principle component:
j,=0.96 x + 0.46; 2 8. 72;= 8. 79; r 1.00; n 74; t-test
for paired values: -1.08; p > 0.05.
20
10 2U 30 40
Figure 5. Comparative determination ofglucose in sera of
patients using the Ektachem system and the SMA 12/60.
Analysis of principle component: y 1.02 x 0.05; 2
7.51; s--4.74;=7.64, s--4.87;r=l.OO;n=171, t-test
for paired values: 4.84; p > 0.05.
Table 5 Day-to-day precision of glucose and urea determination with the Ektachem system(VK coefficient of variation).
In 10 days the concentrations (mmol/1) in various control sera were determined in duplicate analyses (a,b).
control serum
(batch number)
Precilip (661
Seronorm (135)
Validate N (0527087)
Kontrollogen L (3105 A)
Normosic (414 D)
Hyland P (P 11)
Hyland N (NO 4)
Pathotrol E (PT 75 G)
Monitrol II (PTD 58 A)
Monitrol (147 B)
pH-value
after at most
2h after
reconstituation
8,57
7,71
7,55
7,37
7,35
6,81
7,75
5,63
7,07
7,96
glucose
given value mean value 1) VK 1)
6,83
6,70
4,40
5,33
5,39
11,40
4 25
13,20
11,6
a 6,54 1,30
b 6,54 0,94
a 6,55 2,13
b 6,55 1,40
a 4,40 1,70
b 4,45 1,65
a 4,62 2,04
b 4,64 1,69
a 5,15 1,15
b 5,16 1,93
a 10,89 1,93
b 10,98 1,76
a 4,09 1,75
b 4,10 1,82
a 13,26 1,69
b 13,31 1,27
a 11,72 2,19
b 11,76 2,02
a 5,11 2,67
b" 5,15 1,96
urea
given value mean value 1) VK1)
4,88
6,84 6,00 2,16
6,00 1,96
13,4 11,72 2,75
11,87 2,17
6,5 5,72 2,81
5,76 2,63
5,8 5,48 2,83
5,50 2,88
6,24 4,85 2,91
4,81 2,93
15,0 12,54 1,59
12,50 2,56
4,7 4,19 3,06
4,18 3,09
10,2 7,81 2,09
7,86 2,01
11,7 10,32 2,83
10,28 2,27
4,83 4,43 2,92
4,42 3,14
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Table 6 Precision in the series of glucose and urea determinations with the Ektachemsystem
(VK coefficient of variation)
method control serum batch given value V.K.
(mmol/1) (mmol/1) %
1,39 1,40 0,79
28,3 28,60 0,41
4,4 4,43 0,98
11,6 11,74 9,63
glucose Pathonorm L 15
High Control
Validate N 0845058
Monitrol II PTD 58 A
urea Pathonorm L 15 3,50 2,82 1,45
High Control 37,3 36,82 0,58
Validate N 0845058 6,5 5,75 1,17
Monitrol II PTD 58 A 11,7 10,30 1,74
15
15
15
15
15
15
15
15
Table 7 Comparative determination of concentrations of glucose
and urea in sera of patients with lowered creatinine clearance
patient glucose (mmol/1) urea (mmol/1)
13 6,9 6,5
282 3,4 3,5
284 4,8 4,7
375 4,6 4,4
376 4,5 4,2
523 4,6 4,3
143 5,3 5,4
562 4,4 4,3
556 5,4 5,3
163 3,1 2,9
162 5,5 5,5
175 7,1 7,2
179 5,8 5,7
25 3 3,9 3,9
351 4,7 4,6
420 2,5 2,4
423 7,8 7,9
102 4,9 5,0
110 5,3 5,5
305 6,7 6,4
mean value 5,06 4,9 8
42,6 42,3
18,5 18,1
18,7 18,9
13,5 13,4
32,0 32,7
22,0 21,3
32,1 32,7
21,8 21,9
20,4 20,3
2,1 2,2
13,2 13,3
3,2 3,3
12,5 12,8
17,3 17,2
20,5 20,1
12,7 12,9
13,8 14,0
15,2 15,5
32,5 32,2
19,3 19,3
19,20 19,22
creatinine clearance
ml- mina
9
17
20
4
9
10
14
12
8
7
10
13
7
9
3
4
15
10
2
30
15 30 45 60
Figure 6. Comparative determination of urea in sera of
patients using the Ektachem system and Gemsaec.
Analysis of principle component: y 0.99 x 4- 0.13;
Yc 9.66; y:= 9. 73; r 1.00; n 84. t-test for paired values:
0.80; p 0.05.
40
30
20
10 20 30 40 50 6’0
Figure 7. Comparative determination of urea in sera of
patients using the Ektachem system and the SMA 12/60.
Analysis of principle component: y 0.99 x + 0.2; Yc
9.02, s 8.97;= 9.13, s 8.89; r-- 1.00; n 171. t-test
for paired values: --2.85; p 0.05.
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the legends to Figures 4 and 7) differ by less than 1%. This is
also true for various samples from patients suffering from
kidney deficiency (clearance of creatinine under 20 ml/min),
and with high transaminase activities (Tables 7 and 8). Using
the Ektachem system a value below the lower limit of deter-
mination (1.1 mmol/1) was found in only one serum. This
had a glucose value of 1.4 mmol/1. However, this discrepancy
could not be resolved.
In tests with 10 different control sera (Table 5), the mean
values between Ektachem and the comparative method for
the determination of glucose differed by 2%, and for the
determination of urea the difference was 14%. The Ektachem
value for Pathonorm E, however, was below the value
obtained using the urease-GLDH method. A pH value of 5.6
has been measured for this particular control serum (Table
5). It is possible that the buffer capacity in the urea slides
was insufficient to compensate for this comparatively low pH
value. To overcome this the manufacturer recommends that
Table 8 Comparative determinations of glucose and urea concentration in
sera of patients with increased transaminase activities
patient glucose (mmol/1) urea (mmol/l) GOT GPT
u/1 u/1
133 6,7 6,4- 5,7 5,8 58 129
210 4,9 4,7 5,3 5,2 175 135
230 4,8 4,6 4,1 3,9 664 1326
505 4,3 4,0 3,8 3,8 64 40
5 31 4,3 4,0 3,9 3,9 462
5 39 5,4 5,2 4,5 4,6 65 50
088 11,6 11,7 7,2 7,1 87 70
97 5,8 5,9 7,3 7,2 44 110
169 5,6 5,2 4,6 4,8 48 52
130 5,3 5,5 7,1 7,2 52 132
145 6,7 6,9 8,5 8,2 70 93
152 7,5 7,2 3,7 3,5 40 120
205 8,1 7,8 4,5 4,2 62 55
371 4,3 4,4 3,6 3,4 520
188 2,3 2,2 3,0 3,1 62 108
242 4,7 4,8 6,6 6,5 65 75
363 5,4 5,6 9,3 9,2 86
361 5,3 5,2 4,3 4,2 101 112
482 5,1 5,3 1,2 1,3 112 23
450 5,8 5,6 8,8 8,7 50 90
047 11,8 12,0 13,6 13,7 55 26
mean value 5,99 5,91 5,74 5,69
Table 9 Refound values of glucose and urea in pool sera to which various components were added. In absence of exogenic
compounds mean values () and standard deviations (s) were calculated from 15 determinations. Results of analysis which are
outside the range of confidence ( 3s), are marked with an asterisk. The range of confidence is for glucose 11.14 14.08
mmol/1 and for urea 6,23 6.68 mmol/l.
trade name I.N.N. 1) concentration glucose urea
rag/1 (mmol/1) (mmol/l)
Amuno indometacinum 4 13,28 6,47
B utazolidin phenylbutazonum 12 13,06 6,51
Metalcaptase D-penicillaminum 36 12,35 6,5 3
Prolixan azopropazon-d ihydrat 36 13,45 6,5 7
Resochin chloroquinum 5 12,70 6,57
Tanderil oxyphenbutazonum 12 12,67 6,46
Aponal doxepinum 6 12,76 6,43
Megaphen phenothiazinum 20 13,11 6,55
Multum chlordiazepo sidum 1,8 12,26 6,56
Aspirin acidum acetylosali- 100 13,59 6,45
cylicum
Dolviran acidum acetylocali
cylicum, etc.
Novalgin novaminsulfonum 80 12.79 6.45
1) International designation or recommended by
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10-
9-
glucose
0 210 4 dO dO 1(0 120
g/I bovine albumin
Figure 8. Influence o]" albumin on the determination of
glucose and urea with the Ektachem svstem. The glucose
and urea concentrations were the same in all aqueous
solutions.
the control sera for urea determination is reconstituted with
a 20 mmol/1 solution of bicarbonate. The experiments
presented in Table 3 were performed with lyophilised control
sera that had been reconstituted with bidistilled water. Some
of the control sera for glucose determination are suitable
for use as control measurements (Table 5).
No cross contamination could be detected using the
NCCLS procedure (Tables 3 and 4). The mean values obtained
for samples analysed after low concentrations and after high
concentrations showed no significant difference.
Interferences by endogenic compounds
Interference due to bilirubin was not observed in either
method using concentrations of bilirubin up to 340/amol/1.
Increasing concentrations of proteins retards the perox-
idase activity. It has been reported that albumin acts as a
competitive inhibitor [11]. With the Ektachem method,
however, a slight increase in the glucose value is observed
with increasing albumin concentration (Figure 8). Taking an
albumin concentration of 80 g/1 as the norm, at a concen-
tration 120 g/l, a 6% higher, and at 20 g/1 a 6% lower value
for glucose is obtained. In routine diagnostics, however, this
influence may be neglected. This is illustrated in Figure 9.
The sera with protein concentrations above 100 g/1 were
taken from a patient suffering from paraproteinemia. The
determination of urea in this sample was not affected by
protein (Figures 8 and 10).
Curme et al [ll measured a glucose concentration in a
haemolytic sample which was 7% lower than with a compar-
ative method. The authors have not observed any interference
up to concentrations of haemoglobin of 6.4 g/1. Also, no
interference was observed with either of the two methods
due to lipemic turbidity using triglyceridglycerol concen-
trations up to 32 retool/1.
Interferences by exogenic compounds
Using the experimental procedure (Table 9) from a range of
46 compounds that were added to a pool of sera, significant
interferences were only observed with the following
compounds: chloramphenicol, tetracycline and ascorbic
acid. Experiments were repeated adding these compounds
to the same pool of sera in various, but lower concentrat-
ions which more closely approach those actually occurring in
blood (Figures 11 and 12). This showed that only ascorbic
acid produces a significant interference in the determination
of glucose. The relevance of this interference cannot be
Reference methods"
SMA 12/60 (hexokinase)
Eppendorf 5030 (hexokinase)
1,0
go
40 50 60 70 80 90 100 110
g/I protein
Figure 9. Influence of protein on determination ofglucose
concentration with the Ektachem system. The y-axis gives
the values of the ratio between glucose (Ektachem value
in mmol/l) and glucose (Eppendorf endpoint analyzer
5030 value in m mol/l). The range of confidence corre-
sponds to the (2+ 3s) ---range (2 mean value, s standard
deviation) of the 74 values that were used in Figure 3and
which had been obtained from visually transparent sera.
E 1,2
1,0
-. 0,9
0,8
Reference methods:
SMA 2/60
Gemsaec
o
,o 0000
40 50 60 70 80 90 100 120
g/I protein
Figure 10. Influence of protein on determination of urea
concentration with the Ektachem system. The y-axis gives
the values of the ratio between urea (Ektachem value in
m tool/l) and urea (Gemsaec value in mmole/l). The range
of confidence corresponds to the (2+ 3s)-range (2 mean
value, s standard deviation) of the 84 values that were
used in Figure 5 and which had been obtained from
visually transparent sera.
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assessed because the actual levels in patients’ specimen is not
actually determined in the author’s laboratory. After intake
of excessive amounts of ascorbic acid a plasma concentration
of 47 rag/1 (0.27 mmol/1) was measured 121. A patient who
was treated with 250 mg/kg methotrexate [13] provided no
samples with a clear difference between the Ektachem and
comparative methods (Table 10).
In accordance with a proposal by the FDA (Food and
Drug Administration: Proposed Product Class Standard for
Quantitative Measurement of Glucose in Serum or Plasma)
various interfering compounds added to the sample sera must
not alter the result by more than 5 mg/dl. Curme et al [1]
maintain that out of 25 compounds added (most of which
were not tested in this study) this requirement was not
100
40
20 60 80 mg/I chloramphenicol
10 15 20 rng/I tetracyclin
400 800 1200 1600 rng/I methotrexat
Normal dosage overdosage (14)
100 200 300 400 mgll ascorbic acid
Figure 11. Recovery values in percents ofglucose in serum
to which various compounds had been added. The range
of confidence indicated at 88% and 112% corresponds to
the (2 + 3s) range (2 mean value, s standard
deviation) that was obtained from 10 measurements of
the same pool ofserum without the added compounds.
20 4; dO 80 mg/I chl phenicol
10 15 20 mg/I tetracyclin
400 800 1200 1600 rng/I methotrexat
normal dosage*l overdosage (14)
100 200 300 400 mg/I ascorbic acid
Figure 12. Recovery values in percents of urea in serum to
which various compounds had been added. For range of
confidence see legend to Figure 11.
Table 10 Glucose and urea concentrations of a patient treated with infusions of methotrexat
methotrexat
in serum
p. mmol/l
3,1
5,6
6,6
5,1
0,5
291,6
609,1
1095,1
123,1
275,4
6,0
glucose
mmol/1 mmol/l
2,9 2,9
2,8 2,8
4,3 4,1
3,6 3,7
5,8 5,4
3,5 3,6
5,6 5,4
6,5 6,5
6,6 6,7
3,8 3,9
3,3 3,4
urea
mmol/1 mmol/1
2,7 2,8
4,6 4,5
6,9 6,8
7,3 7,2
4,9 4,8
2,5 2,6
2,8 2,8
3,2 3,1
3,7 3,8
2,2 2,1
2,1 2,0
Table 11 Comparison of mean value and coefficient of variation (VK) for daily (A) and for one constant calibration (B)
during 21 days (n=21) with the Ektachem system
glucose
method
Low Control
Wellcomtrol II
High Control
mean value
A B VKA VKB
3,37 3,37 2,97 2,67
11,65 11,97 2,58 2,59
28,35 28,19 1,94 1,21
mean value
A B VKA VKB
3,28
29,28
37,66
3,35 3,05
29.77 2,42
37,66 2,O4
1,79
1,75
1,91
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fulfilled for ascorbic acid (100 mg/dl), thymol (100 g/l), and
lipids (45 g/l).
Following a recommendation by the FDA (i.e. measure-
ments lie within the 95% range of confidence as determined
for the same pool of sera that has not been adulterated with
pharmaceuticals), the manufacturer did not find a significant
interference for urea for the following compounds: bilirubin
(2+ mg/dl, 340 pmol/1),creatinin (10 mg/dl, 88 /amol/1),
dextran 40 (1/gl), sodium salicylate (35 mg/1), uric acid
(10 mg/1, 600/.tmol/1).
Fluoride is an inhibitor for urease and the manufacturer
recommends that any plasma samples with fluoride present
should not be used. With both glucose and urea methods, a
positive bias was observed for serum which has been spiked
with sodium fluoride (Table 7).
Practicability
The system is easy to operate, and it is almost impossible to
make operating mistakes. The technica! reliability of the
instrument has been evaluated because an evaluation instru-
ment was used, which was designed for glucose and urea
determination only. The commercial instrument will be
differ.ent. The control sera were analyzed and calibrations
were carried out daily. The instrument settings remained
fixed during the time of the experiments. The coefficients of
variation were somewhat lower on average for a fixed cali-
bration (Table 11). Therefore, one calibration per batch
seems to be sufficient to obtain the necessary precision of
results.
Conclusion
The determination of concentrations of glucose and urea in
human sera with the Ektachem system for analysis proved to
be very precise and accurate. The range of linearity is
sufficient. For routine medical diagnosis interferences so far
observed can be tolerated. The poor agreement with the
assigned values for controls also causes some concern and
should be investigated further.
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Decision criteria for selecting
analytical instruments
In 1978 the Expert Panel on Instrumentation of the
International Federation of Clinical Chemistry received a
request from its Associate Member for New Zealand, to
help in some way with guidance on the choice of analyti-
cal instrumentation. It was pointed out that relatively
isolated communities such as in New Zealand, often find
it impossible to choose rationally from the large amount
of literature which presents a bewildering array with little
indication as to which instrument is most suitable for a
particular application.
The Expert Panel enlisted the cooperation of the
International Union of Pure and Applied Chemistry’s
Commission on Automation, and together they prepared
a series of papers to be presented at various international
congresses, hopefully covering many of the factors to be
taken into account when choosing instrumentation for the
laboratory. These papers will be printed in the next issue
of the Journal of Automatic Chemistry.
The
Journal of Automatic
Chemistry
The following papers have been accepted for publication
and will be published in future issues.
A semiautomatic system for subsampling heterogenous
foods
Automatic analysis: the laboratory manager’s problems
Use of a simple 8-bit microprocessor as a flexible sequence
controller for developing laboratory automation
Decision criteria for selecting analytical instruments
The determination of pKa and partition data: an
automated approach
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